SCM
ONCE

Sterling Capital Management’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Sterling Capital Management’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-10,947
Closed -$457K – 1071
2015
Q3 		$457K Buy
+10,947
New +$571K ﹤0.01% 779

Other funds holding ONCE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Sterling Capital Management's ONCE Position: Q4 2015 in Review

Sterling Capital Management sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2015, closing a stake of 10,947 shares — an estimated $457K sold.

Sterling Capital Management first reported a position in ONCE in Q3 2015 and held it in 1 quarter. The position peaked at $457K in Q3 2015. 102 funds tracked by Wall St. Rank hold ONCE as of Q4 2015.

  • Sterling Capital Management reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2015 after selling out during the quarter.
  • Sterling Capital Management sold 10,947 Spark Therapeutics, Inc. Common Stock shares in Q4 2015, an estimated $457K.
  • Sterling Capital Management first reported a position in Spark Therapeutics, Inc. Common Stock in Q3 2015 and held it in 1 quarter.
  • Sterling Capital Management's Spark Therapeutics, Inc. Common Stock position peaked at $457K in Q3 2015.
  • 102 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2015.

Based on Sterling Capital Management's 13F filing for Q4 2015, filed 17 Feb 2016.